How to Detect Liver Fibrosis without Liver Biopsy | Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search
Previous

HCV and the Body's Most Important Antioxidant

Back to News Homepage
Next

Shortened Hepatitis C Treatment Increases Relapse Rate

How to Detect Liver Fibrosis without Liver Biopsy

The Editors at Hepatitis Central
July 16, 2007

Print this page

Biotech company IQur’s new blood test for evaluating liver fibrosis has been approved in the UK. The ‘Enhanced Liver Fibrosis Test’ detects and monitors liver damage without the need for an invasive liver biopsy.

Blood test to detect liver damage

11 July 2007
www.mlwmagazine.com

A new blood test that detects and monitors liver damage has now received regulatory approval to be used in the UK.

The ‘Enhanced Liver Fibrosis Test’ (ELF), produced by IQur, a biotech company in the field of liver disease, detects liver problems without the need for invasive biopsies.

Liver damage, or fibrosis, may occur without causing any symptoms so many people remain unaware for decades that they have liver disease. Deaths due to liver disease currently stand at 7,500 a year in the UK.

“This is a massive shift in the area of liver disease,’’ said Professor William Rosenberg, one of the pioneers behind the test. “Liver disease is one of the most common causes of death in the UK and anything that we can do to stem the rise has huge significance for patients and those treating the disease.’’

The new test is available through GP surgeries, health clinics and hospitals. The analysis of samples is undertaken by iQur’s specialist diagnostic service, and the test can be repeated at appropriate intervals to monitor disease progression and response to therapy.

ELF test has been developed by iQur in association with the University of Southampton and Siemens Medical Solutions in the US.

No Comments - be the first!
Share
Share
Previous

HCV and the Body's Most Important Antioxidant

Back to News Homepage
Next

Shortened Hepatitis C Treatment Increases Relapse Rate

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.